Peng D, Gao Y
Department of Endocrinology, the General Hospital of Civil Aviation Administration of China, Beijing 100025, China.
Zhonghua Nei Ke Za Zhi. 2000 Nov;39(11):739-42.
To investigate the protein expression of insulin receptor substrate-1 (IRS-1), protein tyrosine phosphatase with two src-homology 2 (SH-PTP(2)) in adipose tissues of type II diabetic patients, and explore molecular mechanisms of insulin resistance from adipose tissues of type II diabetic individuals.
The levels of protein expression of IRS-1 and SH-PTP(2) in adipose tissues from type II diabetic individuals were measured by Western blot analysis; meanwhile compared the level of protein expression of one's own abdominal subcutaneous and omentum majus adipose tissue from patients with type II diabetes mellitus.
The expression of IRS-1 protein in abdominal subcutaneous (A) 2.14 +/- 0.67 and omentum majus 3.25 +/- 0.70 adipose tissues from patients with type II diabetes mellitus was significantly lower than that of control group [subcutaneous: 4.33 +/- 0.57 (P < 0.001), omentum majus: 8.65 +/- 2.85 (P < 0.05)]. The expression of SH-PTP(2) protein had no difference compared with control group (P > 0.05). The protein expression of IRS-1 was significantly lower in abdominal subcutaneous adipose tissue (1.09 +/- 0.13) than that in omentum majus adipose tissue (2.10 +/- 0.22) from the type II diabetic patients (P < 0.05), but the protein expression of SH-PTP(2) was significantly higher in subcutaneous adipose tissue (70.75 +/- 2.18) than that in omentum majus (43.69 +/- 11.07, P < 0.05).
The abnormal changes in expression of IRS-1 and SH-PTP(2) protein in adipose tissues of the patients with type II diabetic mellitus may be one of the mechanisms of leading to insulin resistance. The abdominal subcutaneous adipose tissue of type II diabetic patients, as visceral adipose tissues, contributes to their insulin resistance.
研究Ⅱ型糖尿病患者脂肪组织中胰岛素受体底物-1(IRS-1)、含两个src同源结构域2的蛋白酪氨酸磷酸酶(SH-PTP2)的蛋白表达情况,探讨Ⅱ型糖尿病患者脂肪组织胰岛素抵抗的分子机制。
采用蛋白质印迹分析法检测Ⅱ型糖尿病患者脂肪组织中IRS-1和SH-PTP2的蛋白表达水平;同时比较Ⅱ型糖尿病患者自身腹部皮下和大网膜脂肪组织的蛋白表达水平。
Ⅱ型糖尿病患者腹部皮下脂肪组织(A)IRS-1蛋白表达为2.14±0.67,大网膜脂肪组织为3.25±0.70,均显著低于对照组[皮下:4.33±0.57(P<0.001),大网膜:8.65±2.85(P<0.05)]。SH-PTP2蛋白表达与对照组相比无差异(P>0.05)。Ⅱ型糖尿病患者腹部皮下脂肪组织IRS-1蛋白表达(1.09±0.13)显著低于大网膜脂肪组织(2.10±0.22)(P<0.05),但皮下脂肪组织SH-PTP2蛋白表达(70.75±2.18)显著高于大网膜脂肪组织(43.69±11.07,P<0.05)。
Ⅱ型糖尿病患者脂肪组织中IRS-1和SH-PTP2蛋白表达异常变化可能是导致胰岛素抵抗的机制之一。Ⅱ型糖尿病患者腹部皮下脂肪组织如同内脏脂肪组织一样,对其胰岛素抵抗有影响。